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Introduction
With the gradual increase of the life expectancy of women, 
the prevalence of women with pelvic organ prolapse (POP) 
is increasing, and 40.8% of postmenopausal women aged 
50 to 79 years who enrolled in the Women’s Health Initiative 
Hormone Replacement Therapy Clinical Trial [1] have been re-
ported to have some degree of POP.
POP is regarded as an abnormal descent or herniation of the 
pelvic organs, including the uterus, anterior and posterior va-
gina, bladder, urethra, and rectum, from their normal anatomi-
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Objective
To demonstrate the significance of bladder outlet obstruction (BOO) in preoperative urodynamic studies (UDS) in women 
who have been diagnosed with pelvic floor dysfunction including pelvic organ prolapsed (POP) and stress urinary 
incontinence (SUI).
Methods 
The medical records of 150 patients with pelvic floor dysfunction who underwent preoperative UDS at Yonsei University 
Health System from 2006 to 2012 were reviewed. Under the criteria of BOO, as a maximal flow rate in free-flow study (Qmax) 
less than 12 mL/sec and a detrusor pressure at Qmax in pressure-flow study (PdetQmax) higher than 20 cmH2O in UDS, they 
were divided into two groups: a group of 50 patients with BOO and a group of 100 patients without BOO. Comparisons 
were made between the patients with and without BOO in preoperative UDS.
Results
In the POP-with-SUI group, 25 patients with BOO had lower mean Qmax (10.0 vs. 25.4 mL/sec, P<0.001), higher PdetQmax 
(49.6 vs. 21.5 cmH2O, P < 0.001), lower maximum cystometric capacity (422.7 vs. 454.0 mL, P=0.007), and higher postvoi-
dal residual volume (44.3 vs. 21.1 mL, P = 0.021) than the patients without BOO. In the SUI-only group, the mean Qmax was 
significantly lower in the 25 patients with BOO (9.4 vs. 25.4 mL/sec, P< 0.001). The mean PdetQmax was significantly higher 
with BOO (39.6 vs. 25.4 cmH2O, P = 0.004). In the univariate analyses, menopause, maximum cystometric capacity, and 
cystoscopic bladder trabeculation were associated with BOO. 
Conclusion 
In the univariate analysis, menopause, MCC and cystoscopic bladder trabeculation were associated with BOO. In the mul-
tivariate model, however, no significant association with BOO was found.
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cal position in the pelvis, which is caused by the weakness of 
the pelvic floor muscle and the connective tissue. Advanced 
POP is often noted to be related with the presence of lower 
urinary tract dysfunction, such as bladder outlet obstruction 
(BOO), urinary incontinence (UI), and detrusor dysfunction [2].
BOO is caused by urethral compression when co-existing 
with not only apical but also posterior as well as anterior 
compartment prolapsed [3]. Prolapse of the bladder or urethra 
and the mechanical obstruction of the urinary system caused 
by uterine prolapse can lead to increased urinary resistance, 
incomplete bladder emptying, and secondary changes in the 
detrusor [4]. Patients with POP have a higher incidence of 
bladder trabeculation, which is the secondary result of BOO 
and is caused by morphological and histological changes 
due to hypertrophy and hyperplasia of the bladder muscle, as 
found in other studies [4-8]. 
There have been few objective studies on female BOO and 
its related symptoms and diagnosis. Some studies have dem-
onstrated that half of all women with POP have a feeling of 
incomplete bladder emptying, but only 30% of the patients 
with advanced POP have urodynamic evidence of BOO [9,10]. 
Some studies tried to suggest an association between BOO 
and bladder trabeculation in stress urinary incontinence (SUI) 
patients, but there are no objective evidences of such.
The aim of this study was to determine the significance of 
BOO in preoperative urodynamic studies (UDS) in women who 
had been diagnosed with pelvic floor dysfunction, including 
POP and SUI. The relationship between BOO and bladder tra-
beculation in patients with POP and SUI was demonstrated. 
Materials and methods
After approval of the Severance Hospital Institutional Review 
Board Committee, the medical records of 150 patients who 
had been diagnosed with pelvic floor dysfunction and who 
underwent preoperative UDS at Yonsei University Health 
System within the period from January 2006 to March 2012 
were reviewed. The patients were divided into two groups: a 
group of 50 patients with BOO and a group of 100 patients 
without BOO in the preoperative UDS. Among the 50 patients 
with BOO, there were 25 patients who had been diagnosed 
with POP-with-SUI and 25 patients who had been diagnosed 
with SUI only. Among the 100 patients without BOO, there 
were 50 patients who had been diagnosed with POP-with-
SUI and 50 patients who had been diagnosed with SUI only. 
All the women provided their medical and gynecologic histo-
ries and underwent cystoscopy, and UDS was performed after 
restoration of the prolapsed organ by the same examiner. POP 
surgery and a combination of procedures were performed by 
an experienced surgeon in the authors’ institution after an 
accomplished informed consent form was obtained from each 
patient. 
A suspicious BOO was determined as a maximal flow rate 
in free-flow study (Qmax) less than 12 mL/sec and a detrusor 
pressure at Qmax in pressure-flow study (PdetQmax) higher than 
20 cmH2O in the UDS [11]. The patients with and without 
BOO were compared in a preoperative UDS, and their base-
line demographics, including their age, body mass index 
(BMI), presence of menopause, history of pelvic surgery, and 
presence of difficult labor, were reviewed retrospectively. The 
parameters of the UDS, such as Qmax (mL/sec), PdetQmax (cmH2O), 
postvoidal residual volume (PVR, mL), maximal cystometric 
capacity (MCC, mL), valsalva leak point pressure (VLPP), 
maximum urethra closure pressure (MUCP), and prevalence 
of detrusor overactivity (DO), were evaluated. The preopera-
tive and postoperative urinary symptoms, including frequency, 
urgency, stress incontinence, urgency incontinence, dysuria, 
and urinary retention, were also assessed, using urogenital 
distress inventory-6 (UDI-6) (Fig. 1) [12]. UDI-6 consists of 
six questionnaires evaluating the subjective improvement of 
the urinary symptoms. The UDI-6 form has a value between 
0 and 3, according to how much the patient is bothered by 
Fig. 1. Urogenital distress inventory-6.
UROGENITAL DISTRESS INVENTORY (UDI-6)
DO YOU EXPEREINCE ANY URINARY INCONTINENCE?           YES          NO 
Name: Date:
Please circle the number that best describes what you are feeling. Use the following as your guide.
 (0) Not at All
 (1) Slightly
 (2) Moderately
 (3) Greatly 
 Do you experience, and if so, how much are you bothered by:
 1. Frequent urination?  (0)   (1)   (2)   (3)
 2. Urine leakage related to the felling of urgency?  (0)   (1)   (2)   (3)
 3. Urine leakage related to physical activity, coughing, or sneezing?  (0)   (1)   (2)   (3)
 4. Small amounts of urine leakage?  (0)   (1)   (2)   (3)
 5. Difficulty emptying your bladder?  (0)   (1)   (2)   (3)
 6. Pain or discomfort in the lower abdomen or genital area?  (0)   (1)   (2)   (3)
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each symptom, whereas in this study, 1 point was given for 
each questionnaire (the score equivalent to UDI-6 score 1 is 
0 point, and that equivalent to UDI-6 score 2 or 3 is 1 point), 
and the scores of the individual patients as well as the total 
scores of the patients with and without BOO were presented.
The site and stage of the POP were decided and categorized 
using the pelvic organ prolapse quantification (POP-Q) system 
[13]. Statistical analysis was performed using two sample t-
tests, the Fisher’s exact test, and univariate and multivariate 
logistic regression analysis, with PASW ver. 18.0 (SPSS Inc., 
Chicago, IL, USA). A P-value of <0.05 was considered statisti-
cally significant.
Results
The mean age of the patients with BOO was 54.5 years, 
and that of the patients without BOO was 58.3 years. The 
comparison of the two groups (with and without BOO) re-
vealed statistical significance in the presence of menopause. 
This could be initially associated with the effect of aging, but 
there was no significant difference in age (Table 1). There 
were no significant differences either in parity, BMI, history 
of pelvic surgery, and preoperative and postoperative urinary 
symptoms, including frequency, urgency, stress incontinence, 
urgency incontinence, dysuria, and urinary retention. Based on 
the UDI-6 form, where 1 point was given to each question-
naire, two groups were formed: one with scores of 3 or more 
and the other with scores of less than 3. Also, there was no 
significant difference between the UDI-6 total scores of the 
patients with BOO and those without BOO (Table 2).
In the POP-with-SUI group, the mean Qmax of the 25 patients 
with BOO was lower than that of the 50 patients without 
BOO (10.0 vs. 25.4 mL/sec, P < 0.001). The patients with BOO 
had a higher mean PdetQmax (49.6 vs. 21.5 cmH2O, P <0.001), 
a lower mean MCC (422.7 vs. 454.0 mL, P = 0.007), and a 
higher mean PVR (44.3 vs. 21.1 mL, P = 0.021). In the SUI-
only group, the mean Qmax was significantly lower in the 25 
patients with BOO (9.4 vs. 25.4 mL/sec, P <0.001), and the 
mean PdetQmax was significantly higher in the same patients 
(39.6 vs. 25.4 cmH2O, P = 0.004). The patients who had dif-
ficult labor were associated with BOO (P = 0.03), and there 
were no significant differences either in age, BMI, history of 
pelvic surgery, menopause, and preoperative UDI-6 score, 
postoperative UDI-6 score, and prevalence of DO (Table 3).
Univariate logistic regression analysis adjusted by group 
(POP-with-SUI and SUI-only) as a covariate was performed to 
determine the effects of each component based on the pres-
Table 1. Basal characteristics (n=160) 
Characteristics
All patients (n=150)
P-value
With BOO (n=50) Without BOO (n=100)
Age (yr)
    Median    54.5 58.3 0.213
    Range    35–77 31–80 −
Parity (median)        3.1 ± 0.5      3.4 ± 0.6 0.352
Body mass index (kg/cm2) 0.157
    <21     2 (4.0)   6 (6.0) −
    21–25     25 (50.0)   60 (60.0) −
    ≥25     23 (46.0)   34 (34.0) −
Previous pelvic surgery 0.273
    No     30 (60.0)   70 (70) −
    Hysterectomy       8 (16.0)   18 (18) −
    Prolapsed surgery     4 (8.0)   1 (1) −
    Other       8 (16.0)   11 (11) −
Menopause (yes/no) 35 (70)/15 (30) 79 (79)/21 (21) 0.048
Values are presented as median ± standard deviation or number (%).
BOO, bladder outlet obstruction.
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ence and absence of BOO. In the univariate analysis, meno-
pause (P = 0.04; odds ratio [OR], 0.52), MCC (P = 0.04; OR, 
0.99), and cystoscopic bladder trabeculation (P = 0.005; OR, 
4.36) were associated with BOO. Age, previous pelvic surgery, 
prevalence of DO, and PVR, however, were not related with 
BOO (Table 4).
Multivariate logistic regression analysis adjusted by vari-
able, which was significantly different from univariate logistic 
regression analysis as a covariate, was performed. In the mul-
tivariate model, however, no significant association with BOO 
was found. 
Discussion
With the improvement of the quality of life and the gradual 
increase of the life expectancy of women, the prevalence of 
women with POP is increasing. As such, the obstetrician-gy-
necologists are increasingly concerned about POP and other 
conditions affecting many elderly people, such as UI.
According to population-based studies, 30.4% of the 
women aged 20 to 59 years in the Swedish population [14] 
and 40.8% of the postmenopausal women aged 50 to 79 
years who were enrolled in the Women’s Health Initiative 
Hormone Replacement Therapy Clinical Trial [1] have some 
degree of POP. It was reported that the proportion of women 
with experienced symptomatic POP was about 2.9% (95% 
CI, 2.1%–3.7%), and that of women with UI was 15.7% (95% 
CI, 13.2%–18.2%) among the women from 20 to more than 
80 years old in a 2008 study in the United States [15].
The important factors affecting POP are history of vaginal 
delivery, number of vaginal deliveries, elevated intra-abdomi-
nal pressure caused by obesity, constipation, chronic coughing 
arising from a pulmonary disease, and previous pelvic surgery, 
Table 2. Comparison of preoperative and postoperative symptoms using UDI‐6
All patients (n=150)
P-value
With BOO (n=50) Without BOO (n=100)
Preoperative symptoms (1 point/0 point)
Question 1a)   6 (12)/44 (88) 14 (14)/86 (86) 0.66
Question 2 42 (84)/8 (16) 81 (81)/19 (19) 0.75
Question 3 11 (22)/39 (78) 37 (37)/63 (63) 0.41
Question 4 10 (20.0)/40 (80.0) 19 (19)/81 (81) 0.66
Question 5               7 (14.0)/43 (86.0) 17 (17)/83 (83) 0.89
Question 6   6 (12.0)/44 (88.0) 15 (15)/85 (85) 0.61
UDI-6 score (total)   0.76
0–2 39 (78.0) 83 (83) −
≥3 11 (22.0) 17 (17) −
Postoperative symptoms (1 point/0 point)
Question 1a) 11 (55.0)/9 (45.0) 17 (54.8)/14 (45.2) 0.78
Question 2   8 (40.0)/12 (60.0)   9 (29)/22 (71) 0.46
Question 3   8 (40.0)/12 (60.0)   8 (25.8)/23 (74.2) 0.51
Question 4   8 (40.0)/12 (60.0)   9 (29)/22 (71) 0.46
Question 5   3 (15.0)/17 (85.0)   6 (19.4)/25 (80.6) >0.99
Question 6   7 (35.0)/13 (65.0)   7 (22.6)/24 (77.4) 0.39
UDI-6 score (total) 0.47
0–2 12 (60.0) 22 (70.9) −
≥3   8 (40.0)   9 (29.0) −
Values are presented as number (%).
UDI‐6, urogenital distress inventroty‐6; BOO, bladder outlet obstruction.
a)Question 1, frequency; question 2, urgency; question 3, stress incontinence; question 4, urgency incontinence; question 5, dysuria; ques-
tion 6, urinary retention; 1 point, the score equivalent to UDI‐6 score 2 or 3; 0 point, the score equivalent to UDI‐6 score 1.
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Table 3. Comparison of the two groups with and without bladder outlet obstruction 
Parameters
POP-with-SUI group (n=75) SUI-only group (n=75)
With BOO 
(n=25)
Without BOO 
(n=50) P-value
With BOO 
(n=25)
Without BOO 
(n=50) P-value
Stage of POP
II/III/IV 2/13/10 7/32/11 0.24 − − −
Difficult labor 0.76 0.03
Yes       15 (60)       26 (52) −       10 (40)         7 (14) −
No       10 (40)       24 (48) −       15 (60)       43 (86) −
Preoperative symptoms 0.68 0.76
UDI-6 score (total)  0–2       17 (60)       43 (86) −       22 (90)       40 (80) −
                             ≥3         8 (40)         7 (14) −         3 (10)       10 (20) −
Postoperative symptoms 0.52 0.59
UDI-6 score (total)  0–2         6 (70)       15 (88.2) −         6 (58.3)         7 (50) −
                              ≥3         3 (30)         2 (11.7) −         5 (41.6)         7 (50) −
Parameters in UDS
VLPP (cmH2O)     92.4 ± 15.42     93.5 ± 16.56 0.47   91.56 ± 15.66   86.52 ± 16.25 0.32 
MUCP (cmH2O)     55.8 ± 17.67   51.64 ± 18.78 0.72     58.3 ± 22.15   52.57 ± 17.29 0.36
Qmax (mL/sec)   10.07 ± 1.57   25.45 ± 5.58 <0.001     9.44 ± 2.12   25.42 ± 6.11 <0.001
PdetQmax (cmH2O)   49.61 ± 10.80   21.54 ± 16.66 <0.001   39.63 ± 12.25   25.48 ± 13.85 0.004
MCC (mL) 422.78 ± 75.77 454.04 ± 67.87 0.007 421.57 ± 90.21 434.04 ± 69.77 0.75
PVR (mL)     44.3 ± 35.66   21.14 ± 27.32 0.021   20.33 ± 23.66     19.9 ± 31.92 0.72
Prevalence of DO >0.99 >0.99
Yes       22 (88.0)       42 (84) −       23 (92)       46 (92) −
No         3 (12.0)         8 (8) −         2 (8)         4 (8) −
Values are presented as number of patients (%) or mean ± standard deviation.
POP, pelvic organ prolapsed; SUI, stress urinary incontinence; BOO, bladder outlet obstruction; UDI‐6, urogenital distress inventroty‐6; 
VLPP, valsalva leak point pressure; MUCP, maximum urethra closure pressire; Qmax, maximal flow rate in free‐flow study; PdetQmax, Qmax in 
pressure‐flow study; MCC, maximal cystometric capacity; PVR, post‐void residual volume; DO, detrusor overactivity.
Table 4. In the univariate logistic regression adjusted by group (POP‐with‐SUI and SUI‐only) 
Parameters OR 95% CI P-value
Age 0.91 0.92–1.06 0.08
Menopause 0.52 0.23–1.01 0.04
Previous pelvic surgery 0.71 0.36–1.98 0.61
Prevalence of DO 0.80 0.35–2.34 0.60
Qmax (mL/sec) 0.61 0.41–0.71 <0.0001
PdetQmax (cmH2O) 1.13 1.03–1.09 <0.0001
MCC (mL) 0.99 0.99–1.06 0.04
PVR (mL) 1.14 0.90–1.02 0.07
Cystoscopic trabeculation 4.36 1.31–14.8 0.005
POP, pelvic organ prolapsed; SUI, stress urinary incontinence; OR, odds ratio; CI, confidential intervals; DO, detrusor overactivity; Qmax, max-
imal flow rate in free‐flow study; PdetQmax, Qmax in pressure‐flow study; MCC, maximal cystometric capacity; PVR, post‐void residual volume.
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especially hysterectomy, which may lead to the disturbance of 
the neural circulation and network [16]. Other factors, such as 
age and estrogen and vitamin C deficiency, which affect the 
connective-tissue support, are also known to cause POP [3,17]. 
The authors’ institution reported [4] that the patients 
with bladder trabeculation were significantly associated 
with higher mean values of the POP stage compared to 
the patients without bladder trabeculation (3.13±0.40 and 
2.86±0.31, P = 0.023), and that the incidence of bladder 
trabeculation was significantly higher in the patients sus-
pected of having BOO than those without BOO (80% vs. 
46.81%, P = 0.046).
The lack of a standard definition of female BOO, there 
were trying to define the urodynamic definition of BOO in 
some previous studies [11,18-21]. In this study, the risk fac-
tors for POP of patients with and without BOO, which was 
defined by the Blaivas-Groutz nomogram [11] (Qmax less than 
12 mL/sec and a detrusor pressure at PdetQmax higher than 20 
cmH2O), were compared via UDS. There were no significant 
differences in age, parity, BMI, history of pelvic surgery, home 
delivery, presence of difficult labor, preoperative and post-
operative urinary symptoms, and prevalence of DO between 
the two groups. Especially, the POP stage had no significant 
association with BOO (P = 0.24). The outcome may have been 
derived from the difference in numbers in each stage (of the 
75 patients in the POP-with-SUI group, 9, 45, and 21 patients 
had POP stage II, III, and IV, respectively). Thus, the future 
study should focus on the correlation between the POP stage 
and BOO by matching the number of patients in the different 
POP stages.
The strengths of this study include the fact that it is a serial 
study of the authors’ institution that included more patients 
than in the previous study. Whereas the previous study sug-
gested possible relationships among bladder trabeculation, the 
POP stage, and BOO, this study focused on BOO and aimed to 
compare the factors influencing it as well as to determine its 
significance in pelvic floor dysfunction patients. Some studies 
tried to suggest an association between BOO and bladder tra-
beculation in SUI, but there are no objective evidences of such. 
This study thus has value in that it held the first trial of the fac-
tors related to BOO in SUI. In the multivariate analysis, however, 
no significant association with BOO was found.
Another strength of this study was its comprehensive evalu-
ation of the factors affecting POP and BOO, for which not 
only objective evaluation by UDS such as VLPP, MUCP, MCC, 
prevalence of DO but also subjective factors such as preopera-
tive and postoperative urinary symptoms were utilized, using 
the UDI-6 form. The Korean version of the UDI-6 form has 
yet to be validated, but as it is currently being used for the 
assessment of subjective urinary symptoms in the urogynecol-
ogy department of many hospitals, it was administered to the 
patients in this study. 
Additionally, all the patients underwent POP surgery and 
a combination of procedures performed by an experienced 
surgeon in the authors’ institution. Further, as there was only 
one UDS examiner in this study, inter-observer variation was 
avoided.
Even though this study had some limitations, a retrospec-
tive chart review of 150 patients diagnosed with SUI with 
and without POP at the authors’ institution was conducted. 
Especially, the UDI-6 form was used in this study to evaluate 
the preoperative and postoperative urinary symptoms of the 
patients as self-reported information; as such, recall bias may 
exist. No significant differences were found, however, in the 
preoperative and postoperative urinary symptoms, including 
frequency, urgency, stress incontinence, urgency incontinence, 
dysuria, and urinary retention, in the comparison of the 
groups with and without BOO (Table 2).
Another limitation was about the deilemma of definition 
of BOO. Akikwala et al. [18] reported that the Blaivas-Groutz 
nomogram overestimated obstruction compared to other cri-
teria. As previously mentioned on other studies, the definition 
and that following results has been a controversial subject.
In conclusion, objective evidences of the diagnosis of BOO 
and of the factors related to it in patients with pelvic organ 
dysfunction were demonstrated in this study, which was a se-
rial study of the authors’ institution that aimed to prove the 
relationship between BOO and cystoscopic bladder trabecula-
tion. Although the results of this study did not have statistical 
significance, it is believed that a prospective randomized trial 
targeting more pelvic floor dysfunction patients and compar-
ing to another criteria of BOO is needed to validate the sig-
nificance of BOO in pelvic floor dysfunction in a preoperative 
UDS in a future study.
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